Walgreens Boots Alliance, Inc. - Common Stock (WBA)
11.21
-0.18 (-1.54%)
Walgreens Boots Alliance is a global healthcare leader that operates a chain of pharmacies, drugstores, and health and wellness retail outlets
The company is known for providing accessible pharmaceutical services and a wide range of health and beauty products. With a commitment to enhancing the health and well-being of its customers, Walgreens Boots Alliance focuses on delivering innovative healthcare solutions, including pharmacy services, immunizations, and health consultations. Additionally, the company engages in retail pharmacy and wholesale distribution, partnering with various healthcare providers to improve patient outcomes and ensure the availability of essential medications and healthcare products.
NEW YORK, March 08, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Shares of pharmacy chain Walgreens Boots Alliance (NASDAQWBA) jumped 7.4% in the morning session after the company agreed to be acquired by Sycamore Partners for $10 billion. The acquisition price represents a roughly 8% premium to the stock's trading price a day before the news was public.
Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Stay updated with the latest market activity on Friday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
BALA CYNWYD, Pa., March 07, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
The $11.45 offer represents an 8% premium to Walgreens stock’s closing price Thursday and 29% on Dec. 9, 2024, the day before the first media reports regarding a potential transaction emerged.
ETFs holding Walgreens stock are adjusting as the company goes private with Sycamore Partners. Short-term volatility expected, but overall impact manageable.
Walgreens Boots Alliance Inc has entered into a definitive agreement to be taken private by Sycamore Partners in a deal valued at $10 billion, the company announced Thursday. The transaction, unanimously approved by Walgreens' board, offers shareholders $11.45 per share in cash at closing.
Walgreens Boots Alliance shares are trading higher in Thursday's after-hours session after the company announced a deal to be acquired by Sycamore Partners.
The Ademi Firm is investigating Walgreens (NASDAQWBA) for possible breaches of fiduciary duty and other violations of law in its transaction with Sycamore.
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Walgreens Boots Alliance (NASDAQWBA) to Sycamore Partners is fair to Walgreens shareholders. Under the terms of the proposed transaction, Walgreens shareholders will receive $11.45 per share in cash at closing and one non-transferable right to receive up to $3.00 in cash per Walgreens share from the future monetization of Walgreens’ debt and equity interests in VillageMD.
